2017
DOI: 10.1002/jbm.b.34039
|View full text |Cite
|
Sign up to set email alerts
|

Sterilization effects on ultrathin film polymer coatings for silicon‐based implantable medical devices

Abstract: Novel biomaterials for medical device applications must be stable throughout all stages of preparation for surgery, including sterilization. There is a paucity of information on the effects of sterilization on sub-10 nm-thick polymeric surface coatings suitable for silicon-based bioartificial organs. This study explores the effect of five standard sterilization methods on three surface coatings applied to silicon: polyethylene glycol (PEG), poly(sulfobetaine methacrylate) (pSBMA), and poly (2-methacryloyloxyet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 43 publications
0
11
0
Order By: Relevance
“…where L (length of pore, 2.325 mm), h (height of pore, 400 nm), n (fixed number of pores on the test substrate, 1.56 Â 10 7 pores), and l (viscosity of water) are fixed, DP (transmembrane pressure) is varied, and Q (volumetric flow rate) is measured. 13,17,56 In vitro protein adsorption (fibrinogen and albumin)…”
Section: Surface Coating Characterizationmentioning
confidence: 99%
See 1 more Smart Citation
“…where L (length of pore, 2.325 mm), h (height of pore, 400 nm), n (fixed number of pores on the test substrate, 1.56 Â 10 7 pores), and l (viscosity of water) are fixed, DP (transmembrane pressure) is varied, and Q (volumetric flow rate) is measured. 13,17,56 In vitro protein adsorption (fibrinogen and albumin)…”
Section: Surface Coating Characterizationmentioning
confidence: 99%
“…Protein adsorption on the surfaces of the substrates was determined by conducting enzyme-linked immunosorbent assay (ELISA) following protocol published previously. 17,44 Substrates were placed in 24-well tissue culture polystyrene (TCPS) plates and incubated with D-PBS for 1.5 h. D-PBS was replaced with 0.5 mL of single protein solution: 1 mg/mL concentration of human fibrinogen (F3879, Sigma-Aldrich) or human albumin (AB19183, Abcam, Cambridge, MA, USA) was added and allowed to incubate at 37 C for 1.5 h. All substrates were rinsed five times with D-PBS. Surfaces were then blocked using bovine serum albumin (A7906, BSA, !98%, Sigma-Aldrich) using 1 mg/mL BSA solution for 1.5 h. The substrates were rinsed five times with D-PBS and transferred to a new 24-well TCPS well.…”
Section: Surface Coating Characterizationmentioning
confidence: 99%
“…Indeed, the recent increase in exploration of SB-based materials for in vivo evaluations brings their clinical use closer to reality. 213,214 Beyond surface uses, there are a variety of promising directions for SB-based zwitterion biomaterials in applications such as wound healing or insulin administration, which may be ripe for translation in future years. 136,215 Many of the possible applications for which the antifouling properties of SB would prove beneficial remain to be explored.…”
Section: Discussionmentioning
confidence: 99%
“…Although the hydration layer influences the water structure by ions in the aqueous medium, protein molecules attached at the interface do not influence the hydration structure. , These findings are important to explain low-protein-adsorption phenomena on these zwitterionic polymers. Biological responses, such as platelet adhesion and bacteria adhesion, following the protein adsorption process on these polymers, are also suppressed, when they are examined in vitro and ex vivo . ,,,, For these polymers to be used as materials for preparing the medical devices, it is necessary to exhibit not only biological performance of the polymers but also their safety and stability for sterilization, , long-term storage, and clinical use. The number of articles concerning these polymers increases year by year, and it is expected that biomedical devices incorporating them will soon be developed in a similar manner to that found with MPC polymers.…”
Section: Concluding Remarks and Future Perspectivementioning
confidence: 99%
“…responses, such as platelet adhesion and bacteria adhesion, following the protein adsorption process on these polymers, are also suppressed, when they are examined in vitro and ex vivo. 111,112,115,116,127−129 For these polymers to be used as materials for preparing the medical devices, it is necessary to exhibit not only biological performance of the polymers but also their safety and stability for sterilization, 130,131 long-term storage, and clinical use. The number of articles concerning these polymers increases year by year, and it is expected that biomedical devices incorporating them will soon be developed in a similar manner to that found with MPC polymers.…”
Section: ■ Cardiovascular Applicationsmentioning
confidence: 99%